Labs to pay $8.5M in false billing settlement

Pharmasan Labs and  NeuroScience, both based in Osceola, Wis., and two executives, Gottfried Kellermann and Mieke Kellermann, have agreed to pay $8.5 million to the federal government to resolve False Claims Act allegations, according to the Department of Justice.

Advertisement

The lawsuit — filed by Pharmasan’s former billing manager Richard Forrest under the qui tam provisiona of the False Claims Act — claimed both companies submitted false information for laboratory services billed to Medicare, as well as violating rules pertaining to services referred by non-physician practitioners. 

According to the complaint, Pharmasan billed government healthcare programs for thousands of tests that did not meet federal and Medicaid guidelines for reimbursement because they were medically unnecessary, experimental or investigative. The lawsuit further alleges Pharmasan intentionally altered its billing codes to prevent detection.

More articles on legal and regulatory: 

Indiana physician who allegedly traded prescriptions for sex pleads guilty
Medi-Cal civil rights case one of the largest in decades
Home healthcare company owner indicted in $450k kickback scheme

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.